secwatch.observer — SEC 8-K summary
======================================

Issuer:     Simulations Plus, Inc. (SLP)
CIK:        0001023459
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001023459-23-000085
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Simulations Plus Q3 revenue $16.2M (+9%), EPS $0.20; maintains FY guidance; completes Immunetrics acquisition
--------------------------------------------------------------------------------

- Q3 revenue $16.2M (+9% YoY); diluted EPS $0.20 (flat); adjusted EBITDA $6.5M (40% margin).
- Software revenue $10.6M (+10%), services $5.6M (+5%); gross margin 82%.
- Nine-month revenue $43.9M (+4%); net income $9.4M ($0.46 EPS) vs $11.5M ($0.56) prior year.
- Completed $20M ASR program: 492,041 shares repurchased at $40.65 avg; dividend of $0.06/share declared.
- Acquired Immunetrics for $15.5M cash + up to $8M earn-out, closed June 16; expands QSP into oncology/immunology.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023459/000102345923000085/0001023459-23-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023459/000102345923000085/slp-20230706.htm
  HTML page:      https://secwatch.observer/filing/0001023459-23-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer